Gene Therapy for Rare Disorders 2022 | Booth #22
February 3, 2022
Meet Veristat at the Gene Therapy for Rare Disorders Conference 2022 in Boston, MA - March 7-10, 2022 at Booth 22
ACDM Annual Conference 2022 | Booth #17
January 20, 2022
Meet Veristat at the ACDM Annual Conference 2022 taking place on the 13th -15th March 2022, Booth #17
2021 TOPRA Awards Event
July 27, 2021
Veristat To Sponsor the TOPRA Awards 2021
London - UK 18th November 2021
Orphan Drug Congress Europe | Booth #54
July 9, 2021
Meet Veristat at the Orphan Drug Congress 2021 taking place on 15-18 November 2021, Booth #54
On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products
April 12, 2021
Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now
Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.
Are your risk-management strategies for clinical trials E6 (R2) Compliant? Learn how to be sure.
Webinar Summary
Patient recruitment continues to be the number one reason for study delays. It is estimated for every day a drug is not on the market, $1 million USD is lost in revenue, and more importantly, patients suffering from illnesses are left waiting for products that can help them achieve their health goals or provide a better quality of life.Veristat to Speak on Risk-Based Monitoring At MassBio Forum
September 18, 2019
Join Veristat and panel of experts at the upcoming MassBio Forum: